Percutaneous Transhepatic Cholangiography (PTHC) in Acute Cholecystitis and Clinical Outcomes

• Register: ClinicalTrials.gov
• Last refreshed on: 7 June 2021
• Main ID: NCT03087747
• Date of registration: 07/03/2017
• Prospective Registration: No
• Primary sponsor: University of Split, School of Medicine
• Public title: Percutaneous Transhepatic Cholangiography (PTHC) in Acute Cholecystitis and Clinical Outcomes
• Scientific title: Percutaneous Drainage in a Setting of Acute Cholecystitis Severity Grade III and Correlation With Clinical Outcomes
• Date of first enrolment: January 1, 2015
• Target sample size: 0
• Recruitment status: Withdrawn
• URL: https://clinicaltrials.gov/show/NCT03087747
• Study type: Observational [Patient Registry]

Countries of recruitment

Croatia

Contacts

• Name: Liana Cambj Sapunar, Professor
• Affiliation: University Hospital Split

Key inclusion & exclusion criteria

Inclusion Criteria:

- clinical markers of acute cholecystitis

- diagnosis confirmed with some imaging technique: computed tomography (CT), ultrasound
(US).

Exclusion Criteria:

- clinical diagnosis was not confirmed with imaging.



Age minimum: N/A
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Cholecystitis, Acute

Elderly Infection

Drain Abscess

Intervention(s)

Procedure: Percutaneous cholecystostomy

Primary Outcome(s)

C-reactive protein (CRP) [Time Frame: Up to 8 weeks.]

Secondary Outcome(s)

White blood cells (WBCs) count [Time Frame: Up to 8 weeks.]

Drainage duration (expressed in days) [Time Frame: Up to 16 weeks.]

Secondary ID(s)

AChol

Source(s) of Monetary Support

Please refer to primary and secondary sponsors